Skip to content

Clinical trials

Phase 3 trials in Sri Lanka

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Phase 3 Country / region: Sri Lanka Clear all

35 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20061
20071
20081
20104
20113
20121
20132
20141
20162
20172
20182
20201
20213
20222
20231
20245
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed20
Recruiting7
Terminated6
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
The George Institute4
Colorado Prevention Center3
Eli Lilly and Company3
Boehringer Ingelheim2
George Medicines PTY Limited2
Lakefront Biotherapeutics NV2
AKARI Therapeutics1
Alvotech Swiss AG1
Anthera Pharmaceuticals1
Bayer1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Heart Failure4
Arthritis, Rheumatoid3
Diabetes Mellitus, Type 23
Hypertension3
Crohn Disease2
Lupus Erythematosus, Systemic2
Stroke2
Ancylostomiasis1
Asphyxia Neonatorum1
Atherosclerosis1

Trials

Showing 26 to 35 of 35. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.